Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reversible Transition between Discrete and 1D Infinite Architectures: A Temperature-Responsive Cu(I) Complex with a Flexible Disilane-Bridged Bis(pyridine) Ligand.
Zhao Y, Nakae T, Takeya S, Hattori M, Saito D, Kato M, Ohmasa Y, Sato S, Yamamuro O, Galica T, Nishibori E, Kobayashi S, Seki T, Yamada T, Yamanoi Y. Zhao Y, et al. Among authors: hattori m. Chemistry. 2023 Jul 6;29(38):e202204002. doi: 10.1002/chem.202204002. Epub 2023 May 15. Chemistry. 2023. PMID: 37084044
Multifunctional Octamethyltetrasila[2.2]cyclophanes: Conformational Variations, Circularly Polarized Luminescence, and Organic Electroluminescence.
Shimada M, Yamanoi Y, Ohto T, Pham ST, Yamada R, Tada H, Omoto K, Tashiro S, Shionoya M, Hattori M, Jimura K, Hayashi S, Koike H, Iwamura M, Nozaki K, Nishihara H. Shimada M, et al. Among authors: hattori m. J Am Chem Soc. 2017 Aug 16;139(32):11214-11221. doi: 10.1021/jacs.7b05671. Epub 2017 Aug 3. J Am Chem Soc. 2017. PMID: 28730816
Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
Bekki T, Shimomura M, Yano T, Akabane S, Hattori M, Mochizuki T, Ono K, Matsubara K, Imaoka K, Ishikawa S, Watanabe A, Sato S, Ohdan H. Bekki T, et al. Among authors: hattori m. Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300-1. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38679678 No abstract available.
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.
Yoshinami T, Nagai SE, Hattori M, Okamura T, Watanabe K, Nakayama T, Masuda H, Tsuneizumi M, Takabatake D, Harao M, Yoshino H, Mori N, Yasojima H, Oshiro C, Iwase M, Yamaguchi M, Sangai T, Kosaka N, Tajima K, Masuda N. Yoshinami T, et al. Among authors: hattori m. Breast Cancer. 2024 Apr 20. doi: 10.1007/s12282-024-01575-5. Online ahead of print. Breast Cancer. 2024. PMID: 38642245
2,562 results